Ancora Advisors LLC has modestly boosted its stake in Johnson & Johnson by 0.5% during the first quarter. Recent filings with the SEC reveal the fund purchased an additional 1,335 shares, bringing its total holdings to 262,034.
Subscribe
Industry News
Stock Market
Ancora Advisors LLC Increases Stock Position in Johnson & Johnson $JNJ
Photo by Ticker Report
Key Takeaways:
- Ancora Advisors LLC increased its Johnson & Johnson stake by 0.5%
- This adjustment occurred during the first quarter
- The fund bought an additional 1,335 shares
- Ancora now holds 262,034 shares of the company
- The information was revealed through an SEC filing
Introduction
Ancora Advisors LLC recently reported a 0.5% rise in its stake in Johnson & Johnson, a detail disclosed through its most recent Securities and Exchange Commission (SEC) filing. The increase underscores the firm’s measured confidence in one of the world’s well-known healthcare companies.
Background on Ancora Advisors
Although the feed does not offer extensive details about Ancora Advisors LLC, the mention of the firm’s SEC filing highlights its commitment to regulatory transparency. Essentially, the investment fund tracks and updates its holdings as required by law, offering a glimpse into its portfolio adjustments.
The Investment Increase
During the first quarter, Ancora Advisors LLC purchased an additional 1,335 shares of Johnson & Johnson. This purchase represents a 0.5% uptick in the fund’s position. Following this adjustment, the firm holds a total of 262,034 shares in the healthcare giant.
Significance of the Timing
The increase in Johnson & Johnson shares occurred during the first quarter, a time when investors often recalibrate their portfolios based on annual performance reviews and market forecasts. While the original feed does not elaborate on the fund’s specific investment strategy, the timing suggests a deliberate approach to strengthening its stake in a well-established brand.
Official SEC Filing
The exact figures regarding Ancora’s Johnson & Johnson holdings come from the firm’s SEC filing, an authoritative source that confirms the legitimacy of the reported stake. The filing ensures greater transparency, enabling analysts and investors alike to track changes in public companies’ ownership structures.
Concluding Thoughts
This filing offers a precise snapshot of Ancora Advisors LLC’s incremental commitment to Johnson & Johnson. Details like the 0.5% increase and share totals serve as tangible markers of the fund’s strategy, connecting investors and interested parties to the ever-evolving movements within equity markets.
